NCT00720291View on ClinicalTrials.gov

Inflammation and Treatment of Bacterial Vaginosis Near Term

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

November 23, 2010

Study Completion Date

November 23, 2010

Conditions
Bacterial Vaginosis
Interventions
DRUG

Metronidazole

Patients who are randomly assigned to receive Metronidazole will receive 500 mg po bid Metronidazole for 7 days

DRUG

Placebo

Patients who are randomly assigned to receive a placebo will receive a placebo pill po bid for 7 days.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT00720291 - Inflammation and Treatment of Bacterial Vaginosis Near Term | Biotech Hunter | Biotech Hunter